Clinical Markers and Diagnostics for Diagnosing Cerebral Infarction

Area of Science:

• Neurology
• Biomedical Engineering
• Medical Diagnostics

Background:

• Cerebral infarction, characterized by restricted blood supply to the brain due to vessel occlusion, is a critical neurological condition.
• Current diagnostic methods primarily rely on advanced imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI).
• There is a growing need for innovative, non-invasive monitoring tools for neurological disorders, including stroke.

Purpose of the Study:

• To review recent advancements in biomarkers for cerebral infarction.
• To discuss emerging biosensor technologies for the diagnosis of brain infarction.
• To explore the potential of non-invasive external brain monitoring for stroke detection.

Main Methods:

• Literature review of recent research on cerebral infarction biomarkers.
• Analysis of current and emerging biosensor technologies for neurological monitoring.
• Discussion of diagnostic systems utilizing biosensors for brain infarction.

Main Results:

• Identification of novel biomarkers associated with cerebral infarction.
• Overview of various biosensor types and their applications in neurology.
• Exploration of the integration of biosensors into diagnostic systems for stroke.

Conclusions:

• Biosensors represent a promising avenue for non-invasive detection and diagnosis of cerebral infarction.
• Advancements in biomarkers and biosensor technology are crucial for improving stroke management.
• Future research should focus on the clinical translation and validation of these novel diagnostic approaches.